Influence of patient co-payments on atypical antipsychotic choice in Poland: implications once generic atypicals are available.

Influence of patient co-payments on atypical antipsychotic choice in Poland: implications once generic atypicals are available.

Item
http://www.wikidata.org/entity/Q42687717
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across EuropeCan authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications.Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries.Distribution and trends in outpatient utilization of generic versus brand name psychopharmaceuticals during a ten-year period in Croatia.Potential to enhance the prescribing of generic drugs in patients with mental health problems in austria; implications for the future.Demand-side policies to encourage the use of generic medicines: an overview.Impact of delisting ARBs, apart from losartan, on ARB utilisation patterns in Denmark: implications for other countries.Possible ways to enhance renin-angiotensin prescribing efficiency: Republic of Serbia as a case history?Evolutions in both co-payment and generic market share for common medication in the Belgian reference pricing system.Changes in the utilization of venlafaxine after the introduction of generics in Sweden.Generic atypical antipsychotic drugs in Belgium: their influence and implications.Differences in utilization rates between commercial and administrative databases: implications for future health-economic and cross-national studies.Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implications.
P2860

Influence of patient co-payments on atypical antipsychotic choice in Poland: implications once generic atypicals are available.

Item
http://www.wikidata.org/entity/Q42687717
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Influence of patient co-paymen ...... neric atypicals are available.
@en
Influence of patient co-paymen ...... neric atypicals are available.
@nl
type
label
Influence of patient co-paymen ...... neric atypicals are available.
@en
Influence of patient co-paymen ...... neric atypicals are available.
@nl
prefLabel
Influence of patient co-paymen ...... neric atypicals are available.
@en
Influence of patient co-paymen ...... neric atypicals are available.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921
P356
P1433
P1476
Influence of patient co-paymen ...... neric atypicals are available.
@en
P2093
P2860
P2888
P304
P31
P356
10.2165/11318840-000000000-00000
P433
P478
P577
P6179
P698
P921